5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.92▼ | 0.92▼ | 0.92▼ | 0.92▼ | 0.99▼ |
MA10 | 0.94▼ | 0.94▼ | 0.95▼ | 0.92▼ | 10.41▼ |
MA20 | 0.96▼ | 0.95▼ | 0.93▼ | 1.02▼ | 34.87▼ |
MA50 | 0.93▼ | 0.97▼ | 0.91▼ | 13.21▼ | 205.31▼ |
MA100 | 0.99▼ | 0.91▲ | 0.95▼ | 43.66▼ | N/A |
MA200 | 0.92▼ | 1.04▼ | 2.67▼ | 126.85▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.007▼ | -0.004▼ | -0.003▼ | 1.094▲ | 8.116▲ |
RSI | 41.669▼ | 45.355▼ | 46.275▼ | 20.805▼ | 23.070▼ |
STOCH | 21.167 | 17.171▼ | 23.827 | 49.239 | 0.415▼ |
WILL %R | -92.209▼ | -92.863▼ | -92.863▼ | -62.451 | -99.576▼ |
CCI | -99.694 | -101.688▼ | -87.797 | -22.424 | -74.319 |
Wednesday, April 24, 2024 05:00 PM
A California-based immunotherapy company with local operations received good news this week that the U.S. Food and Drug Administration has approved its bladder cancer treatment drug. ImmunityBio Inc. ...
|
Wednesday, April 24, 2024 07:00 AM
Final results of CORE-001 Phase 2 trial of cretostimogene in combination with pembrolizumab for the treatment of BCG-unresponsive NMIBC -IRVINE, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- , Inc.
|
Wednesday, April 24, 2024 04:13 AM
On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, and all-day activities. It sells its ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
25/04/24 | 0.9094 | 0.9094 | 0.9094 | 0.9094 | 0 |
24/04/24 | 0.9439 | 0.9579 | 0.8905 | 0.9484 | 954,669 |
23/04/24 | 0.93 | 1.03 | 0.89 | 0.97 | 2,266,293 |
22/04/24 | 0.821 | 0.94 | 0.8202 | 0.9099 | 1,080,789 |
19/04/24 | 1.02 | 1.04 | 0.86 | 0.88 | 1,881,153 |
18/04/24 | 0.9934 | 1.07 | 0.96 | 1.02 | 2,544,451 |
17/04/24 | 0.84 | 1.215 | 0.8302 | 1.13 | 8,557,812 |
16/04/24 | 0.844 | 0.8888 | 0.7451 | 0.8769 | 3,419,902 |
15/04/24 | 0.7369 | 0.839 | 0.6505 | 0.77 | 3,984,566 |
12/04/24 | 0.8828 | 0.8828 | 0.725 | 0.7499 | 2,318,599 |
|
|
||||
|
|
||||
|
|